Search

Your search keyword '"Paulson, A.S."' showing total 21 results
Start Over Author "Paulson, A.S." Publication Year Range Last 50 years
21 results on '"Paulson, A.S."'

2. 361P Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal cancer (mCRC): Patient-reported outcomes (PROs) from ph II study MOUNTAINEER

Author

Wu, C., primary, Strickler, J.H., additional, Cercek, A., additional, Siena, S., additional, André, T., additional, Ng, K., additional, Van Cutsem, E., additional, Paulson, A.S., additional, Hubbard, J., additional, Coveler, A., additional, Fountzilas, C., additional, Kardosh, A., additional, Kasi, P.M., additional, Lenz, H.J., additional, Ciombor, K.K., additional, Elez Fernandez, M.E., additional, Hsu, L-I., additional, Stecher, M., additional, Zhao, K., additional, and Bekaii-Saab, T., additional

Published
2022
Full Text
View/download PDF

3. LBA27 Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC

Author

Strickler, J.H., primary, Cercek, A., additional, Siena, S., additional, André, T., additional, Ng, K., additional, Van Cutsem, E., additional, Wu, C., additional, Paulson, A.S., additional, Hubbard, J., additional, Coveler, A., additional, Fountzilas, C., additional, Kardosh, A., additional, Kasi, P.M., additional, Lenz, H.J., additional, Ciombor, K.K., additional, Fernandez, M.E. Elez, additional, Bajor, D.L., additional, Stecher, M., additional, Feng, W., additional, and Bekaii-Saab, T., additional

Published
2022
Full Text
View/download PDF

4. 1133P Additional practice-informing adverse event patterns and management in the KRYSTAL-1 phase II study of adagrasib (MRTX849) in patients with KRASG12C-mutated NSCLC

Author

Zhang, J., primary, Leventakos, K., additional, Leal, T.A., additional, Pennell, N., additional, Barve, M., additional, Paulson, A.S., additional, Bazhenova, L., additional, Johnson, M.L., additional, Chao, R.C., additional, Velastegui, K., additional, Qian, C., additional, Bleker, W., additional, and Spira, A., additional

Published
2022
Full Text
View/download PDF

5. 575P Phase Ib/II study of ompenaclid (RGX-202-01), a first-in-class oral inhibitor of the creatine transporter SLC6A8, in combination with FOLFIRI and bevacizumab (BEV) in RAS mutated (RASmt) second-line (2L) advanced/metastatic colorectal cancer (mCRC): Updated results

Author

Hendifar, A., Gong, J., Spigel, D.R., Basu-Mallick, A., Espinosa, A., Misleh, J.G., Richards, D., Boles, J., Fakih, M., Paulson, A.S., Chung, K., Cohn, A., Gupta, M., Johnson, K., Bechar, N., Hoffman, K.A., Spector, S., Szarek, M., Wasserman, R., and Rosen, L.S.

Published
2024
Full Text
View/download PDF

7. 1625P Multicenter, randomized, parallel group, phase II study to establish the efficacy and safety of CBP501, cisplatin, and nivolumab for ≥ third-line treatment of patients with exocrine pancreatic cancer and WBC

Author

Enzler, T., Nguyen, A., Misleh, J., Cline, V.J., Johns, M.E., Shumway, N., Paulson, A.S., Siegel, R., Larson, T., Messersmith, W., Richards, D., Chaves, J., Pierce, E., Zalupski, M., Sahai, V., Orr, D., Kawabe, T., Ruste, S.A., and Haun, A.

Published
2023
Full Text
View/download PDF

8. 1619P Health-related quality of life with nalirifox versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): EORTC QLQ-C30 results from the NAPOLI 3 trial

Author

Melisi, D., Macarulla, T., de la Fouchardiere, C., Pazo Cid, R.A., Chandana, S., Dean, A., Kiss, I., Lee, W., Goetze, T.O., Van Cutsem, E., Paulson, A.S., Bekaii-Saab, T., Pant, S., Hubner, R., Xiao, Z., Zhang, L., Benzaghou, F.M., O'Reilly, E.M., and Wainberg, Z.A.

Published
2023
Full Text
View/download PDF

9. 646P Phase Ib/II study of ompenaclid (RGX-202-01), afirst-in-class oral inhibitor of the creatine transporter SLC6A8, in combination with FOLFIRI and bevacizumab (BEV) in RAS mutated (RASm) second-line (2L) advanced/metastatic colorectal cancer (mCRC)

Author

Hendifar, A., Spigel, D.R., Basu-Mallick, A., Richards, D., Fakih, M., Boles, J., Gupta, M., Chung, K., Cohn, A., Espinosa, A., Hourdequin, K.C., Johnson, K., Michalski, J.M., Misleh, J.G., Mukkamala, S., Paulson, A.S., Ratnam, S., Shao, S.H., Wasserman, R., and Rosen, L.S.

Published
2023
Full Text
View/download PDF

11. FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)

Author

Vogel, A., primary, Sahai, V., additional, Hollebecque, A., additional, Vaccaro, G., additional, Melisi, D., additional, Al-Rajabi, R., additional, Paulson, A.S., additional, Borad, M.J., additional, Gallinson, D., additional, Murphy, A.G., additional, Oh, D.-Y., additional, Dotan, E., additional, Catenacci, D.V., additional, Van Cutsem, E., additional, Lihou, C.F., additional, Zhen, H., additional, Féliz, L., additional, and Abou-Alfa, G.K., additional

Published
2019
Full Text
View/download PDF

13. Unchanged cerebral blood flow and oxidative metabolism after acclimatization to high altitude.

Author

Moller, K., Paulson, O.B., Hornbein, T.F., Colier, W.N.J.M., Paulson, A.S., Roach, R.C., Holm, S., Knudsen, G.M., Moller, K., Paulson, O.B., Hornbein, T.F., Colier, W.N.J.M., Paulson, A.S., Roach, R.C., Holm, S., and Knudsen, G.M.

Abstract

Item does not contain fulltext, The authors investigated the effect of acclimatization to high altitude on cerebral blood flow and oxidative metabolism at rest and during exercise. Nine healthy, native sea-level residents were studied 3 weeks after arrival at Chacaltaya, Bolivia (5,260 m) and after reacclimatization to sea level. Global cerebral blood flow at rest and during exercise on a bicycle ergometer was measured by the Kety-Schmidt technique. Cerebral metabolic rates of oxygen, glucose, and lactate were calculated by the Fick principle. Cerebral function was assessed by a computer-based measurement of reaction time. At high altitude at rest, arterial carbon dioxide tension, oxygen saturation, and oxygen tension were significantly reduced, and arterial oxygen content was increased because of an increase in hemoglobin concentration. Global cerebral blood flow was similar in the four conditions. Cerebral oxygen delivery and cerebral metabolic rates of oxygen and glucose also remained unchanged, whereas cerebral metabolic rates of lactate increased slightly but nonsignificantly at high altitude during exercise compared with high altitude at rest. Reaction time was unchanged. The data indicate that cerebral blood flow and oxidative metabolism are unaltered after high-altitude acclimatization from sea level, despite marked changes in breathing and other organ functions.

Published
2002

17. Estimation of Stable Law Parameters: Stock Price Behavior Application.

Author

Leitch, R.A. and Paulson, A.S.

Subjects
*SECURITIES, *STOCK prices, *ESTIMATION theory, *STABILITY (Mechanics), *STOCK price forecasting, *ECONOMIC trends, *EMPIRICAL research
Abstract

A point of considerable interest is whether the asymmetric stable laws rather than the symmetric stable laws provide for a closer representation of the behavior of security prices. Our empirical results indicate that the asymmetric laws are more appropriate than the symmetric stable laws. A new estimation procedure is used to obtain the estimates of parameters of the stable laws for 20 randomly selected stocks from the New York Stock Exchange, Estimates of the skewness parameter are explicitly obtained for the first time. The estimates are compared with those obtained under the assumption of symmetry and are also compared with the estimates provided by the method of Fama and Roll [13]. [ABSTRACT FROM AUTHOR]

Published
1975
Full Text
View/download PDF

20. Modified weighted squared error estimation procedures with special emphasis on the stable laws

Author

Paulson, A.S. and Delehanty, T.A.

Abstract

Two families of parameter estimation procedures for the stablelaws based on a variant of the characteristic function are provided. The methodology which produces viable computational procedures for the stable laws is generally applicable to other families of distributions across avariety of settings. Both families of procedures may be described as a modified weighted chi-squared minimization procedure, and both explicitlytake account of constraints on the parameter space. Influence functions for and efficiencies of the estimators a r e given. If l, x2, ..., xn is a random sample from an unknown distribution F, a method for determining the stable law to which F is attracted is developed. Procedures for regression and autoregression with stable error structurear e provided. A number of examples are given.

Published
1985
Full Text
View/download PDF

21. 323P NALIRIFOX versus nab-paclitaxel and gemcitabine (Gem+NabP) in treatment-naïve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Subgroup analysis of patients aged 65 years or older in NAPOLI 3.

Author

Macarulla Mercade, T., Pazo Cid, R.A., Womack, M., Cubillo Gracian, A., Zervoudakis, A., Hatoum, H., Chung, V., Patel, A., Paulson, A.S., Pant, S., O'Reilly, E.M., Hubner, R., Van Cutsem, E., Bekaii-Saab, T., Zhang, L., Li, J., Chen, H., Maxwell, F., Wainberg, Z.A., and Melisi, D.

Subjects
*PANCREATIC duct, *SUBGROUP analysis (Experimental design), *GEMCITABINE, *ADENOCARCINOMA, *METASTASIS
Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results